Skip to content{"success":true,"data":{"id":"twse-mops-yvep5x","title":"公告本公司受台新證券邀請，舉辦實體法說會","summary":"符合條款第四條第XX款：12 事實發生日：115/10/21 1.召開法人說明會之日期：115/10/21 2.召開法人說明會之時間：14 時 30 分 3.召開法人說明會之地點：敦南摩天大樓(台北市敦化南路二段97號11樓) 4.法人說明會擇要訊息：本公司受台新證券邀請，舉辦實體法說會，由經營團隊向法人及投資者說明公司研發及展業最新狀況。 懷特新藥為台灣首家以新藥研發為核心的上市公司，成功開發兩項獲衛福部核准上市的處方新藥：「懷特血寶®」為全球首項治療癌因性疲憊症的處方新藥，已納入第四期乳癌患者中重度疲憊症狀的健保給付；「懷特痛寶®」為全球首款口服納布啡新藥，用於緩解急性中度至重度疼痛。公司亦開發具特定功效訴求的保健產品，積極拓展國內外營收並推進獲利目標。 5.其他應敘明事項：相關資訊將依規定揭露於公開資訊…","canonicalUrl":"https://mops.twse.com.tw/mops/web/t05st01?TYPEK=all&co_id=4108&encodeURIComponent=1&firstin=1&inpuType=co_id&off=1&step=1&year=115&spoke_date=20261002&spoke_time=145525","sourceName":"TWSE Market Observation Post System","sourceUrl":"https://mops.twse.com.tw/mops/web/t05st01","publishedAt":"2026-10-02T06:55:25.000Z","updatedAt":null,"language":"zh-TW","timeZone":"Asia/Taipei","region":"taiwan","country":"TW","market":"Taiwan","topics":["company-announcement","taiwan"],"relatedAssets":["4108"],"importance":"normal","image":null,"imageRights":null,"contentType":"company-announcement","disclosure":"Official company announcement from 懷特; use the filtered MOPS search page to verify the complete filing.","provenance":{"sourceId":"twse-mops","sourceType":"exchange","official":true,"verification":"PRIMARY_SOURCE_METADATA","fetchedAt":"2026-10-03T01:53:27.711Z","stale":true,"archived":true,"classificationMethod":"RULE_BASED"}},"meta":{"generatedAt":"2026-10-03T01:56:48.473Z","providers":[{"id":"jiguang-news-archive","name":"Jiguang Finance source archive","kind":"news","status":"degraded","itemCount":1,"cache":"STALE","fetchedAt":"2026-10-03T01:53:27.711Z","sourceUrl":"https://jiguang.uk/sources.html","message":"Archived publisher metadata; original publication and fetch times retained. Archive availability is not source freshness."}],"stale":true,"apiVersion":"v2"},"error":null}